Sotorasib Plus Panitumumab Significantly Improves Outcomes in Colorectal Cancer
Combination treatment of sotorasib plus panitumumab prolongs progression-free survival in those with metastatic colorectal cancer and the KRAS G12C mutation.
Vectibix Amgen Sotorasib Lumakras Ravil Sayfullin University Of Connecticut Taiho Oncology Pharmacy Leaders Track
Source: pharmacytimes.com